Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 14 of 29
Leveraging mHealth Messaging to Promote Adherence in Teens With CKD
NCT03651596
A New Treatment for Mechanical Nasal Obstruction
NCT03456115
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
NCT03627299
The Time-Restricted Intake of Meals Study
NCT03527368
Pilot Study of the Liver Live Donor Champion Program
NCT03580629
Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)
NCT04396041
Interventions Made to Preserve Cognitive Function
NCT03616535
Reducing Disability Following Hospital Discharge in Vulnerable Older Adults: The CAPABLE Intervention
NCT03456128
Transnasal Therapy for Acute Migraine Attack
NCT04129567
Ketamine for Treatment of MS Fatigue
NCT03500289
The Diet Gout Trial
NCT03569020
Trial of Roflumilast in Asthma Management (TRIM)
NCT03532490
Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy
NCT03558204
Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
NCT03492099
Auricular Point Acupressure to Manage Pain in Patients With Alzheimer's Disease and Related Disorders
NCT03393546
A Comparative Effectiveness Demonstration Project for Linkage and Retention in PrEP Care for Men Who Have Sex With Men
NCT03442192
A Pilot Study of Remote Monitoring to Improve Health Related Quality of Life of Men Following Prostate Cancer Treatment.
NCT03434535
Technology Based Community Health Nursing to Improve Combination Anti-Retroviral Therapy (cART) Adherence and Virologic Suppression in Youth Living With HIV
NCT03600103
Building on Needle Exchange to Optimize Prevention & Treatment
NCT03567174
Acellular Adipose Tissue (AAT) for Soft Tissue Reconstruction
NCT03544632
A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis
NCT03423121
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy
NCT03526263
Hemodynamics Response to Upper Airway Obstruction in Marfan Syndrome
NCT03985657
The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol
NCT03164512
Maternal Buprenorphine-naloxone Treatment and the Infant
NCT03291847
Implementation of the Live Donor Champion Program
NCT03435510
Buspirone for Opioid Tapering
NCT03521960
Study of Pioglitazone in Sporadic Inclusion Body Myositis
NCT03440034
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial
NCT03350750
Evolocumab in Acute Coronary Syndrome
NCT03515304
Effect of Late Dinner on Nocturnal Metabolism
NCT03525717
Effect of Evolocumab on Coronary Endothelial Function
NCT03500302
Differences in Cannabis Impairment and Its Measurement Due to Route of Administration
NCT03122691
Ultra High Field MRI of Focal Pediatric Epilepsy
NCT03318237
Effects of Repeated Memory Training on Memory Function and Addiction Related Processes
NCT03285256
Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
NCT03345160
Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms
NCT03035799
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
NCT03500315
Baltimore HEARS: Hearing Health Equity Through Accessible Research & Solutions
NCT03442296
EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses
NCT03485924
The Role of Skin Care Regimen in Skin Health
NCT03497130
Cultural Adaptation and Piloting of a Smoking Cessation Intervention for Smokers With HIV
NCT03580460
Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children
NCT03441126
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
NCT03462030
Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease Patients
NCT02925065
Behavioral Activation-Rehabilitation to Improve Depressive Symptoms & Physical Function After Acute Respiratory Failure
NCT03431493
Five, Plus Nuts and Beans for Kidneys
NCT03299816
Scrambler Trial for Pain in NMOSD
NCT03452176
Auricular Point Acupressure: Examining the Scientific Underpinnings of Pain Relief
NCT03634527
Pilot of Zinc Acetate to Improve Chronic Cough
NCT03135522
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.